Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors

Molecular Cancer Therapeutics
José M MazaricoFrancisco X Real

Abstract

Choline kinase α (CHKα) plays a crucial role in the regulation of membrane phospholipid synthesis and has oncogenic properties in vitro. We have analyzed the expression of CHKα in cell lines derived from pancreatic ductal adenocarcinoma (PDAC) and have found increased CHKα expression, associated with differentiation. CHKα protein expression was directly correlated with sensitivity to MN58b, a CHKα inhibitor that reduced cell growth through the induction of apoptosis. Accordingly, CHKα knockdown led to reduced drug sensitivity. In addition, we found that gemcitabine-resistant PDAC cells displayed enhanced sensitivity to CHKα inhibition and, in vitro, MN58b had additive or synergistic effects with gemcitabine, 5-fluorouracil, and oxaliplatin, three active drugs in the treatment of PDAC. Using tissue microarrays, CHKα was found to be overexpressed in 90% of pancreatic tumors. While cytoplasmic CHKα did not relate to survival, nuclear CHKα distribution was observed in 43% of samples and was associated with longer survival, especially among patients with well/moderately differentiated tumors. To identify the mechanisms involved in resistance to CHKα inhibitors, we cultured IMIM-PC-2 cells with increasingly higher concentrations of M...Continue Reading

References

Nov 15, 1985·Biochemical Pharmacology·J LloverasL Douste-Blazy
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Dec 11, 1997·Oncogene·R Hernández-AlcocebaJ C Lacal
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Mar 9, 2004·Progress in Lipid Research·Chieko AoyamaKozo Ishidate
Jul 5, 2005·Cancer Research·Ana Ramírez de MolinaJuan Carlos Lacal
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Oct 19, 2005·Cancer Research·Egidio IorioFranca Podo
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Dec 1, 2007·Cancer·Dan S Zuckerman, David P Ryan
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Nov 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kaiyumars ContractorStephen Mangar
Nov 18, 2011·Nature Reviews. Cancer·Kristine GlundeSabrina M Ronen
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Nov 6, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marie-France PenetZaver M Bhujwalla

❮ Previous
Next ❯

Citations

Jul 26, 2016·Frontiers in Oncology·Marina BagnoliDelia Mezzanzanica
Jun 9, 2018·Pharmaceutical Patent Analyst·Hermann Am Mucke
Jul 26, 2018·Future Medicinal Chemistry·Gianluca RubbiniLuisa Carlota López-Cara
Mar 27, 2019·Cancer Metastasis Reviews·Smitha R PillaiRobert J Gillies
Nov 5, 2019·Frontiers in Microbiology·Tahl ZimmermanSalam A Ibrahim
Jun 3, 2021·Pharmaceutics·Juan Carlos LacalJoaquín M Campos
Aug 21, 2021·Bioorganic & Medicinal Chemistry Letters·Francesca QuartieriPaola Gnocchi
Aug 29, 2021·Pharmaceutics·Yunqing LiEric O Aboagye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis